Table I.
Patient demographics
| Patient no. | Sex | Age (y) | Diagnosis | Age at diagnosis (y) | Serum IgG/IgA/IgM level at diagnosis (g/L) | Through serum IgG level (g/L) | Replacement therapy | Pulmonary complications |
|---|---|---|---|---|---|---|---|---|
| 1 | F | 79 | CVID | 59 | 2.5/<0.1/0.1 | 5.5 | IVIG | Bronchiectasis, fibrosis |
| 2 | M | 32 | XLA | 1 | 1/<0.1/0.1 | 9 | IVIG | Bronchiectasis |
| 3 | M | 36 | CVID | 32 | 3.2/>0.2/<0.2 | 5.5 | IVIG | Bronchiectasis, noduli |
| 4 | F | 45 | CVID | 33 | 2.5/<0.2/0.3 | 5.4 | IVIG | Bronchiectasis |
| 5 | M | 54 | CVID | 29 | 1.5/<0.2/<0.2 | 6.5 | IVIG | Fibrosis, mild bronchiectasis |
| 6 | M | 39 | CVID | 24 | 4.0/<0.2/0.4 | 6.0 | IVIG | Bronchiectasis, noduli |
| 7 | M | 42 | XLA | 1 | 1/<0.2/0.2 | 7.6 | IVIG/SCIG | Bronchiectasis |
| 8 | M | 57 | CVID | 22 | 2.5/<0.2/<0.2 | 7.0 | IVIG | Bronchiectasis |
| 9 | F | 49 | CVID | 33 | 2.3/<0.2/<0.2 | 6.0 | IVIG | Bronchiectasis |
| 10 | M | 51 | CVID | 48 | <0.5/<0.2/<0.2 | 6.2 | IVIG | Bronchiectasis, noduli |
| 11 | M | 46 | CVID | 18 | 2.2/<0.2/<0.2 | 6.5 | IVIG | Bronchiectasis |
| 12 | M | 68 | CVID | 24 | 1.7/<0.2/<0.2 | 6.0 | IVIG | Bronchiectasis |
F, Female; IVIG, intravenous immunoglobulin; M, male; SCIG, subcutaneous immunoglobulin.